The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Plight of the Retail Pharmacist

The Plight of the Retail Pharmacist

March 12, 2020 • By Philip Seo

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The Government, Here to Help

Articles on this topic begin with the same piece of advice: Talk to your pharmacist. I imagine every time pharmacists hear this sort of advice being given, they must sigh. It’s not that they don’t want to talk to us. It’s just that between filling prescriptions, fielding phone calls and administering vaccines, they don’t have enough time.

You Might Also Like
  • Do You E-Prescribe—or Just Think You Do?
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • The Pharmacist’s Role in Managing Rheumatic Diseases
Explore This Issue
March 2020
Also By This Author
  • Space & Other Races

Ronald Reagan famously said, “The nine most terrifying words in the English language are, ‘I’m from the government, and I’m here to help.’” In this case (and perhaps in others) he may have been wrong. Having the government turn a regulatory eye toward PBMs is a good thing.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The inner workings of PBMs are famously opaque. Ohio State Senator Dave Burke makes the following analogy: “If you knew how much a yard of concrete costs, you know how many yards are in a mile and you can estimate how much you should spend on concrete … When the person who is doing that work isn’t telling you how much they paid for the concrete—they just tell you how much it costs for a mile of road—that gets to be a very expensive highway.”14

Increasingly, both state and federal govern­ments are noticing the tremendous role PBMs play in the delivery of nearly 6 billion prescriptions in the U.S. every year.15 Greater transparency in this industry should benefit all of us.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

This won’t be enough, however, to extricate pharmacists from their current situation or allow them more time to provide vital clinical services. For pharmacists, it’s hard to imagine anything but a legislative solution. With this in mind, in 2018, Illinois established the Collaborative Pharmaceutical Task Force, which was “charged with discussing and making recommendations on how to further advance the practice of pharmacy in a manner that recognizes the needs of the healthcare system, patients, pharmacies, pharmacists and pharmacy technicians.”16

The task force has made several recommendations to the Illinois legislature, including mandatory work breaks and penalties for pharmacies who fail to give their pharmacists an adequate amount of time to do their jobs properly and safely.

In 2000, the Doctor of Pharmacy degree became the entry-level pharmacy degree. This clinical degree gives pharmacists education and patient experience they would be eager to put to work—if only they had enough time to do so.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Even legislating pharmacists’ time may not be enough. Notably, the task force elected not to set a maximum number of prescriptions that pharmacists could be expected to fill in an hour, deeming such thresholds arbitrary. The task force was also silent on what sort of penalties should befall a pharmacy that sets unreasonable productivity goals for pharmacists.

That said, it’s a good start. I hope other states follow suit, because it’s important that we acknowledge pharmacists for what they are—a vital link in the delivery of healthcare for our patients.

After all, my nephew is counting on them. 

Pages: 1 2 3 4 5 | Single Page

Filed Under: Electronic Health Records, Legislation & Advocacy, Rheuminations Tagged With: pharmacy benefit managers (PBMs), Prescription drugsIssue: March 2020

You Might Also Like:
  • Do You E-Prescribe—or Just Think You Do?
  • Kentucky Launches Probe into Drug Overcharges by Pharmacy Benefit Managers
  • The Pharmacist’s Role in Managing Rheumatic Diseases
  • In-Office Pharmacist Improves Patient Care

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.